Jesse Bloom and colleagues explained results of a recent study showing 1% of children tested had COVID-19 antibodies, about at the same rate as adults.
Dr. Gary Lyman’s work with the COVID-19 and Cancer Consortium is referenced, revealing that patients with active cancer have a higher risk of death after contracting SARS-CoV-2.
Dr. Steve Pergam commented on the need for public health to be driven by science and the value of the CDC.
Trevor Bedford commented on the possibility of COVID-19 infection in early January, suggesting it was likely flu.
Allison Black explained COVID-19 contact tracing apps, and how they can be leveraged to slow COVID-19 spread.
Trevor Bedford is quoted on an updated analysis suggesting the WA1 COVID-19 patient was not the initial start to the outbreak in Washington.
Louise Moncla discussed new research suggesting a second introduction of COVID-19 led to the outbreak in Washington.
New research from the Hutch's health economics group HICOR and Dr. Veena Shankaran, suggesting nearly 75% of patients with advanced colon cancer experience financial hardship as a result of treatment is discussed.
The first virtual Hutch Award ceremony and winner Dee Gordon are profiled.
The Hutch Award and 2020 winner Dee Gordon are profiled, specifically his philanthropic work and how he got into baseball.
Trevor Bedford discussed his updated analysis suggesting the COVID-19 outbreak began in Seattle in February.
Trevor Bedford’s analysis of COVID-19 genomes suggesting Washington’s outbreak came from an alternative source than the original patient is referenced.
Trevor Bedford’s tweets on the start of the COVID-19 outbreak in Washington and patient WA1 are discussed.
Dr. Larry Corey is quoted on COVID-19 vaccine development progress.
Louise Moncla commented on mutations in SARS-CoV-2 and the lack of knowledge around the impact they have on the virus.
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19.
President Dr. Thomas Lynch discussed Fred Hutch’s work related to COVID-19 virology, epidemiology and vaccine programs.
Dr. Larry Corey suggested potential timeframes for the development of a COVID-19 vaccine.
Dr. Larry Corey discussed the current status of COVID-19 vaccine trials.
President Dr. Thomas Lynch explained the work Fred Hutch is doing on COVID-19 research and vaccines.
Allison Black weighed in on COVID-19 contact tracing apps and the features they need to be effective.
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19, saying more research is needed.
Dr. Elizabeth Halloran explained how we can use COVID-19 models to our advantage, and her recent modeling work and some of the caveats of model predictions.
Trevor Bedford is quoted on the lack of full COVID-19 suppression in the U.S. and the implications on further physical distancing policies.
Dr. Larry Corey is quoted for the announcement of COVID-19 vaccine trials.
Trevor Bedford is listed for receiving a Webby Special Achievement award for Nextstrain.
Dr. Larry Corey explained COVID-19 vaccine strategy and the current status of research around COVID-19 in this video interview with Science.
Dr. Steve Pergam commented on the shutdown of SCAN by the FDA.
Dr. Thomas Lynch and his live virtual chat with GeekWire are highlighted.
Bloomberg cited the CovidWatch study as one of the ways Amazon is working to stop COVID-19.
Dr. Keith Jerome discussed COVID-19 virology, the possibility of reinfection, and transmission.
The Covidwatch study is profiled, with Dr. Michael Boeckh explaining the study goals.
Trevor Bedford’s comments on the COVID-19 status and lack of viral suppression in the U.S. are referenced.
Dr. Nancy Davidson described plans to reopen SCCA safely as COVID-19 cases decline in Washington.
Dr. Trevor Bedford weighed in on when COVID-19 arrived in the U.S., the origins of the virus, and more.
Dr. Elizabeth Halloran discussed COVID-19 testing, strategy, and modeling with other biostatisticians and epidemiologists studying the virus.
Dr. Joshua Schiffer commented on the feasibility of staying safe from COVID-19 in large group gatherings such as concerts.
Steven Heinkoff explained his at home CUT&Tag protocol and how he was able to bring his lab work home.
Ruth Etzioni explained the complications of COVID-19 modeling and the issues with the predictions they can make.
The SCAN program is explored, specifically it’s challenges and goals to track COVID-19 spread.
Dr. Larry Corey discussed COVID-19 vaccine development and clinical trials.
KIRO 7 covered the CovidWatch program, led by Dr. Michael Boeckh, which aims to better understand COVID-19.
Dr. Larry Corey commented on COVID-19 vaccine trials and strategy.
The SCAN Initiative and the role of Gates Ventures in the program are discussed.
Dr. Monica Thakar commented on her work using natural killer cells to target solid tumors.
Trevor Bedford’s genomic analysis exploring the spread of COVID-19 across the U.S. is highlighted, along with Nextstrain.
The SCAN initiative and Gates Notes article on the program are discussed.
The SCAN initiative is profiled by Gates Notes, mentioning Fred Hutch as a partner.
Dr. Larry Corey is quoted on the need for collaboration and multiple COVID-19 vaccines, in relation to the release of a co-authored piece on COVID-19 vaccine development in Science.
The Science piece co-authored by Drs. Larry Corey, Anthony Fauci, Francis Collins and John Mascola is cited.
Dr. Larry Corey’s co-authored editorial in Science, explaining a roadmap to a COVID-19 vaccine and calling for a variety of approaches and collaboration, is discussed.
Business Insider referenced an editorial piece co-written by Drs. Larry Corey, Anthony Fauci and other experts on COVID-19 vaccine development.
GeekWire featured Dr. Larry Corey’s Science perspective, co-authored with Drs Anthony Fauci, John Mascola and Francis Collins, on proposed COVID-19 vaccine plans.
Dr. Larry Corey is discussed along with the co-authors Drs. Anthony Fauci, John Mascola and Francis Collins, on a Science perspective piece on the development of a COVID-19 vaccine.
GeekWire highlighted a Bank of America grant that will fund Fred Hutch COVID-19 response and the purchase of medical supplies for SCCA.
KOMO profiled the COVIDWatch study led by Dr. Michael Boeckh to track COVID-19 in the population.
Trevor Bedford’s discovery of COVID-19 community spread through the Seattle Flu Study is referenced.
Allison Black is mentioned for a segment where she discussed COVID-19 tracking and her work in the Bedford lab.
A SWOG study led by Joseph Unger is featured, specifically findings that insurance plays a large role in whether a patient benefits from clinical trials.
Dr. Keith Jerome is quoted on the impact that early physical distancing measures had in lowering COVID-19 rates in Washington.
Dr. Elizabeth Halloran explained how easily accessible and repeated testing, contract tracing and isolation when sick could keep COVID-19 under control without a vaccine.
Dr. Jim Olson’s work with tumor paint to identify cancerous tissue and the motivation behind his research are discussed.
Trevor Bedford weighed in on serology testing, the true COVID-19 incidence in the U.S., and how we could use blood samples to retroactively test for COVID-19.
Bloomberg quoted Trevor Bedford on statements suggesting that further research is needed to determine if one COVID-19 strain is more transmissible than others.
Dr. Elizabeth Halloran discussed the need for increased COVID-19 testing and contact tracing to justify loosening physical distancing measures
STAT covered the new COVIDWatch study and partnership with Amazon, aimed at learning more about COVID-19’s infection rate and if infection confers immunity.
Trevor Bedford’s statements on the implications of a mutation in SARS-Cov-2’s spike proteins are referenced.
Business Insider discussed Nextstrain work and Trevor Bedford’s comments on COVID-19 lineages and the unknown impact on transmissibility.
Dr. Ruth Etzioni explained the intricacies of modeling and how that relates to COVID-19 predictions.
Trevor Bedford’s statements on the impacts of a SARS-Cov-2 mutation are cited, saying we need further research to determine if it impacts transmissibility.
Dr. Josh Schiffer explained the complexity of COVID-19 immune response and variability across patients.
Dr. Steve Pergam criticized those neglecting to follow physical distancing restrictions.
Trevor Bedford’s commentary on a COVID-19 spike mutation is referenced, suggesting we don’t know the impact of the mutation on transmissibility.
Dr. Ruth Etzioni commented on the IHME model and conclusions being drawn from that model.
Trevor Bedford stated that it’s not possible SARS-CoV-2 was circulating in the U.S. in or before November 2019.
Kelly O’Brien discussed COVID-19 and the value of giving to scientific progress.
Trevor Bedford’s statements predicting continued COVID-19 infections across the U.S. are cited.
Trevor Bedford’s commentary on the lack of accuracy of some COVID-19 antibody tests is included.
Dr. Gary Lyman discussed the risk cancer patients face with COVID-19 and his work with the COVID-19 and Cancer Consortium.
Louise Moncla provided insight to why there are likely unknown early February COVID-19 deaths.
Dr. Steve Pergam discussed the importance of early detection of COVID-19 in Washington’s virus response.
Rachel Issaka weighed in on the need to continue cancer and other chronic disease management and prevention work despite COVID-19.
Trevor Bedford reinforced the scientific reasons why COVID-19 did not originate from a lab, but rather a natural setting.
Dr. Elizabeth Halloran Ruth Etzioni explained how COVID-19 models help scientists and policy makers understand the impact of different restrictions on viral spread.